TRSSF
TerrAscend Corp. [TRSSF] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
TRSSF Stock Summary
Top 10 Correlated ETFs
TRSSF
Top 10 Correlated Stocks
TRSSF
In the News
High & Dry: Banking crisis to further choke funding for cannabis sector
The global banking turmoil threatens to squeeze U.S. cannabis companies already struggling with meager funding sources by drying up support from regional lenders and tightening fundraising from alternative avenues.
TerrAscend retains ‘Buy' rating from Canaccord with reduced price target following 4Q results
TerrAscend Corp. (CSE:TER, OTCQX:TRSSF) has retained a ‘Buy' rating but a reduced price target of C$2.85 from Canaccord Genuity's analysts following the release of fourth-quarter results ending December 31, 2022. For the quarter, the analysts noted that TerrAscend reported net revenues of US$69 million, a 4.2% increase from the previous quarter and slightly ahead of their forecast of US$68.5 million for the period.
2 Marijuana Stocks To Buy This Monday 2023?
Marijuana Stocks To Watch To Start The New Week The post 2 Marijuana Stocks To Buy This Monday 2023? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Analyst calls of the week: NVIDIA, DocGo, TerrAscend, Newmont Gold and more
TerrAscend Corp. (TRSSF) Q4 2022 Earnings Call Transcript
TerrAscend Corp. (OTCQX:TRSSF) Q4 2022 Earnings Conference Call March 16, 2023 5:00 PM ET Company Participants Jason Wild - Executive Chairman Ziad Ghanem - President and COO Keith Stauffer - CFO Conference Call Participants Kenric Tyghe - ATB Capital Markets Andrew Partheniou - Stifel Eric Des Lauriers - Craig-Hallum Capital Glenn Matson - Ladenburg Noel Atkinson - Clarus Securities Andrew Semple - Echelon Capital Markets Operator Good afternoon. My name is JP, and I will be your conference operator today.
Top Marijuana Penny Stocks In March? 2 For Traders Now
Are Penny Pot Stocks On Watch In March? The post Top Marijuana Penny Stocks In March? 2 For Traders Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Pragmatic Cannabis Investing
Pelorus Equity Group's Rob Sechrist shares valuable advice for retail investors in the cannabis space. Scale is not the ultimate driver of cannabis companies.
TerrAscend set to fully capitalize on TSX uplisting strategy, Stifel analysts say
Analysts at Stifel GMP said TerrAscend Corp's application to list on the Toronto Stock Exchange (TSX) is more likely than not to be successful, with expanded investor access to the stock and higher trading volumes potentially leading to the stock achieving a valuation re-rating. In a note to clients, the analysts said they were maintaining their ‘Buy' rating and C$4.50 price target for the stock of the North American cannabis operator following the uplisting application announcement.
TerrAscend applies for Toronto Stock Exchange listing in ‘evolving regulatory environment'
TerrAscend Corp (CSE:TER, OTCQX:TRSSF), a leading North American cannabis operator, has announced that it has applied to list its common shares on the Toronto Stock Exchange. The company said it expects to first implement an internal reorganization in order to qualify for the TSX's minimum listing requirements, adding that this will require approval from existing shareholders.
Best US Marijuana Penny Stocks For Investors In March 2023
Top Penny Pot Stocks With Momentum In 2023 The post Best US Marijuana Penny Stocks For Investors In March 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
TRSSF Financial details
TRSSF Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Revenue per share | 0.76 | 1.02 | |
| Net income per share | 0.02 | -1.23 | |
| Operating cash flow per share | -0.11 | 0 | |
| Free cash flow per share | -0.25 | 0 | |
| Cash per share | 273.44 | 0.12 | |
| Book value per share | 786.09 | 1.31 | |
| Tangible book value per share | -104.22 | -0.04 | |
| Share holders equity per share | 786.09 | 1.31 | |
| Interest debt per share | 4.2 | 0.17 | |
| Market cap | 1.78B | 276.12M | |
| Enterprise value | -77.83B | 290.59M | |
| P/E ratio | 290.31 | -0.92 | |
| Price to sales ratio | 8.02 | 1.11 | |
| POCF ratio | -55.98 | -10.57K | |
| PFCF ratio | -24.51 | -4.2K | |
| P/B Ratio | 0.01 | 0.86 | |
| PTB ratio | 0.01 | 0.86 | |
| EV to sales | -350.48 | 1.17 | |
| Enterprise value over EBITDA | -1.52K | -1.01 | |
| EV to operating cash flow | 2.45K | -11.12K | |
| EV to free cash flow | 1.07K | -4.42K | |
| Earnings yield | 0 | -1.08 | |
| Free cash flow yield | -0.04 | 0 | |
| Debt to equity | 1.54 | 1.18 | |
| Debt to assets | 0.61 | 0.54 | |
| Net debt to EBITDA | -1.56K | -0.05 | |
| Current ratio | 60.46 | 3.47 | |
| Interest coverage | 0 | 0 | |
| Income quality | -5.19 | 0.09 | |
| Dividend Yield | 0 | 0 | |
| Payout ratio | 0 | 0 | |
| Sales general and administrative to revenue | 0.36 | 0.46 | |
| Research and developement to revenue | 0 | 0 | |
| Intangibles to total assets | 0.45 | 0.47 | |
| Capex to operating cash flow | 1.28 | 1.52 | |
| Capex to revenue | -0.18 | 0 | |
| Capex to depreciation | -2.46 | -1.61 | |
| Stock based compensation to revenue | 0.07 | 0 | |
| Graham number | 19.3 | 6.02 | |
| ROIC | 0 | -0.54 | |
| Return on tangible assets | 0 | -0.81 | |
| Graham Net | -827.41 | -1.27 | |
| Working capital | 134.62B | 70.14M | |
| Tangible asset value | -30.36B | -8.86M | |
| Net current asset value | -216.1B | -281.89M | |
| Invested capital | 0.01 | 0.13 | |
| Average receivables | 0 | 7.47B | |
| Average payables | 0 | 0 | |
| Average inventory | 0 | 21.18B | |
| Days sales outstanding | 24.52K | 32.86 | |
| Days payables outstanding | 0 | 0 | |
| Days of inventory on hand | 157.13K | 114.46 | |
| Receivables turnover | 0.01 | 11.11 | |
| Payables turnover | 0 | 0 | |
| Inventory turnover | 0 | 3.19 | |
| ROE | 0 | -0.93 | |
| Capex per share | -0.14 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.77 | 0.24 | 0.26 | 0.26 | 0.75 | |
| Net income per share | 0.02 | -0.08 | 0.05 | -1.23 | 0.06 | |
| Operating cash flow per share | -0.11 | -0.09 | -0.06 | 0.01 | -0.01 | |
| Free cash flow per share | -0.15 | -0.14 | -0.12 | -0.01 | 0.01 | |
| Cash per share | 275.98 | 0.44 | 0.21 | 0.15 | 0.12 | |
| Book value per share | 793.38 | 2.46 | 2.14 | 1.08 | 1.31 | |
| Tangible book value per share | -105.19 | -0.31 | -0.19 | -0.2 | -0.04 | |
| Share holders equity per share | 793.38 | 2.46 | 2.14 | 1.08 | 1.31 | |
| Interest debt per share | 4.24 | 1.35 | 1.14 | 1.16 | 0.17 | |
| Market cap | 1.76B | 1.2B | 575.26M | 325.58M | 276.12M | |
| Enterprise value | -76.65B | 1.39B | 804.72M | 576.62M | 290.59M | |
| P/E ratio | 71.91 | -18.39 | 10.88 | -0.26 | 5 | |
| Price to sales ratio | 7.95 | 24.23 | 8.88 | 4.86 | 1.52 | |
| POCF ratio | -55.82 | -63.85 | -35.67 | 210.73 | -175.74 | |
| PFCF ratio | -40.41 | -41.21 | -19.41 | -158.66 | 139.01 | |
| P/B Ratio | 0.01 | 2.32 | 1.07 | 1.19 | 0.86 | |
| PTB ratio | 0.01 | 2.32 | 1.07 | 1.19 | 0.86 | |
| EV to sales | -345.18 | 28.07 | 12.42 | 8.6 | 1.59 | |
| Enterprise value over EBITDA | -2K | 23.23K | 23.46 | -1.75 | 5.69 | |
| EV to operating cash flow | 2.42K | -73.95 | -49.89 | 373.22 | -184.96 | |
| EV to free cash flow | 1.76K | -47.73 | -27.15 | -281 | 146.3 | |
| Earnings yield | 0 | -0.01 | 0.02 | -0.96 | 0.05 | |
| Free cash flow yield | -0.02 | -0.02 | -0.05 | -0.01 | 0.01 | |
| Debt to equity | 1.54 | 0.98 | 0.86 | 1.63 | 1.18 | |
| Debt to assets | 0.61 | 0.49 | 0.46 | 0.62 | 0.54 | |
| Net debt to EBITDA | -2.05K | 3.17K | 6.69 | -0.76 | 0.28 | |
| Current ratio | 60.46 | 1.26 | 0.98 | 0.66 | 3.47 | |
| Interest coverage | 0 | -1.41 | -1.6 | -32.08 | 0 | |
| Income quality | -5.15 | 1.15 | -1.22 | 0 | -0.01 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.36 | 0.42 | 0.46 | 0.4 | 0.49 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.45 | 0.57 | 0.59 | 0.46 | 0.47 | |
| Capex to operating cash flow | 0.38 | 0.55 | 0.84 | -2.33 | -2.26 | |
| Capex to revenue | -0.05 | -0.21 | -0.21 | -0.05 | 0.02 | |
| Capex to depreciation | -3.1 | -1.86 | -1.77 | -0.48 | -0.47 | |
| Stock based compensation to revenue | 0.01 | 0.07 | 0.07 | 0.04 | -0.01 | |
| Graham number | 19.48 | 2.07 | 1.59 | 5.46 | 1.29 | |
| ROIC | 0 | -0.02 | -0.01 | -0.51 | 0 | |
| Return on tangible assets | 0 | -0.04 | 0.03 | -0.79 | 0.04 | |
| Graham Net | -835.08 | -1.75 | -1.46 | -1.46 | -1.27 | |
| Working capital | 134.62B | 38.87M | -3.09M | -58.95M | 70.14M | |
| Tangible asset value | -30.36B | -64.89M | -47.27M | -52.01M | -8.86M | |
| Net current asset value | -216.1B | -324.03M | -326.33M | -333.27M | -281.89M | |
| Invested capital | 0.01 | 0.54 | 0.52 | 1.04 | 0.13 | |
| Average receivables | 0 | 7.47B | 22.64M | 20.06M | 20.19M | |
| Average payables | 0 | 24.61M | 53.37M | 59.61M | 30.84M | |
| Average inventory | 0 | 21.19B | 59.21M | 51.88M | 47.86M | |
| Days sales outstanding | 6.05K | 41.86 | 30.82 | 24.09 | 11.08 | |
| Days payables outstanding | 0 | 128.31 | 123.85 | 130.12 | 0 | |
| Days of inventory on hand | 38.74K | 167.02 | 117.04 | 104.2 | 39.68 | |
| Receivables turnover | 0.01 | 2.15 | 2.92 | 3.74 | 8.12 | |
| Payables turnover | 0 | 0.7 | 0.73 | 0.69 | 0 | |
| Inventory turnover | 0 | 0.54 | 0.77 | 0.86 | 2.27 | |
| ROE | 0 | -0.03 | 0.02 | -1.14 | 0.04 | |
| Capex per share | -0.04 | -0.05 | -0.05 | -0.01 | 0.01 |
TRSSF Frequently Asked Questions
What is TerrAscend Corp. stock symbol ?
TerrAscend Corp. is a CA stock , located in Mississauga of On and trading under the symbol TRSSF
Is TerrAscend Corp. buy or a sell ?
3 stock analysts have 3 predictions with a medium analyst target price of $4.1. The lowest prediction is $2.85 and the highest is $6.45
What is TRSSF stock prediction ?
What is TerrAscend Corp. stock quote today ?
TerrAscend Corp. stock price is $1.4484 today.
Is TerrAscend Corp. stock public?
Yes, TerrAscend Corp. is a publicly traded company.
Company Profile
- Volume Average 281.51K
- Market Capitalization 473.29M
- Employee 742
- CEO Mr. Jason Garrett Wild R.Ph.
- Headquarters Mississauga,ON,CA
- IPO Date 2017-11-17
-
Website
https://www.terrascend.com 
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. In addition, it owns various synergistic under Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. brands. As of July 26, 2022, the company operated 27 dispensaries, including 3 Cookies dispensaries in Michigan and 1 in Toronto. TerrAscend Corp. was incorporated in 2017 and is headquartered in Mississauga, Canada.
